The objective of this mechanism-based research is to devise a safe and efficient, synthetic lipid- based gene carrier for use in parenteral gene therapy in animals. We postulate that molecular strategies to deliver nucleic acids by viral membrane fusion proteins can be mimicked using less complex lipids. We will design and synthesize lipids that mediate a triggered-membrane fusion and assemble them with plasmid DNA to create a sub-100 nm, nanolipid particle (NLP) that mediates high transfection with low toxicity in animals. The research plan contains four specific aims.
Specific aim 1 : To design, synthesize and characterize novel lipids that alter their charge, interfacial hydrophobicity and phase preference at low pH. The design explores the effect of systematic alterations in the chemical structure of the head group, linker region and hydrophobic portion of the lipids on liposome collapse at low pH.
Specific aim 2 : To formulate lipids synthesized in aim 1 so that they undergo a low pH triggered lamellar to a hexagonal phase change and to characterize the formulations to confirm their phase preference.
Specific aim 3 : To measure the transfection activity and cytotoxicity of NLP formulations encapsulating luciferase encoding plasmid DNA as a function of the amount of lipid that binds to the cell. To measure the rate, location and extent of cytoplasmic contents delivery using fluorescence confocal microscopy and correlate this with the pH of the compartment when delivery is first observed. To test the hypothesis that incorporation of an appropriate targeting ligand or membrane destabilizing peptide can further increase gene transfer.
Specific aim 4 : To characterize the extent and duration of gene transfer in liver hepatocytes or in a flank tumor in mice as a function of NLP composition after a low volume intravenous dose of an optimized targeted NLP. Completion of these specific aims will result in a 'lipid engineered'synthetic gene carrier with an in vivo gene transfer efficiency approaching that of current viral vectors. The resulting NLP will be a non- inflammatory vector in circulation and mediate rapid cytoplasmic transfer of nucleic acids after internalization into cells. Success in this research will enable safe and effective gene therapy for a variety of currently untreatable genetic disorders and neoplastic diseases.

Public Health Relevance

The objective of this mechanism-based research plan is to devise safe and efficient nanolipid particulate (NLP) gene carriers for parenteral gene therapy. Our plan lays out a systematic study of the biophysics, cell biology and in vivo delivery properties of these novel NLP using sophisticated fluorescent techniques. Completion of the plan could lead to greatly improved non-viral DNA vectors that enable gene therapy cures for currently untreatable liver genetic diseases as well as gene therapies to slow cancer progression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB003008-09
Application #
8501446
Study Section
Special Emphasis Panel (ZRG1-BST-M (02))
Program Officer
Tucker, Jessica
Project Start
2003-09-22
Project End
2014-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
9
Fiscal Year
2013
Total Cost
$309,216
Indirect Cost
$105,273
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Venditto, Vincent J; Dolor, Aaron; Kohli, Aditya et al. (2014) Sulfated quaternary amine lipids: a new class of inverse charge zwitterlipids. Chem Commun (Camb) 50:9109-11
Guo, Xin; Gagne, Lucie; Chen, Haigang et al. (2014) Novel ortho ester-based, pH-sensitive cationic lipid for gene delivery in vitro and in vivo. J Liposome Res 24:90-8
Kohli, Aditya G; Kierstead, Paul H; Venditto, Vincent J et al. (2014) Designer lipids for drug delivery: from heads to tails. J Control Release 190:274-87
Venditto, Vincent J; Szoka Jr, Francis C (2013) Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliv Rev 65:80-8
Walsh, Colin L; Nguyen, Juliane; Tiffany, Matthew R et al. (2013) Synthesis, characterization, and evaluation of ionizable lysine-based lipids for siRNA delivery. Bioconjug Chem 24:36-43
Sockolosky, Jonathan T; Szoka, Francis C (2013) Periplasmic production via the pET expression system of soluble, bioactive human growth hormone. Protein Expr Purif 87:129-35
Nguyen, Juliane; Walsh, Colin L; Motion, J P Michael et al. (2012) Controlled nucleation of lipid nanoparticles. Pharm Res 29:2236-48
Perttu, Emily K; Kohli, Aditya G; Szoka Jr, Francis C (2012) Inverse-phosphocholine lipids: a remix of a common phospholipid. J Am Chem Soc 134:4485-8
Huang, Zhaohua; Li, Weijun; Szoka Jr, Francis C (2012) Asymmetric 1-alkyl-2-acyl phosphatidylcholine: a helper lipid for enhanced non-viral gene delivery. Int J Pharm 427:64-70
Walsh, Colin L; Nguyen, Juliane; Szoka, Francis C (2012) Synthesis and characterization of novel zwitterionic lipids with pH-responsive biophysical properties. Chem Commun (Camb) 48:5575-7

Showing the most recent 10 out of 24 publications